Among 141 ovarian cancer patients, 27 (19.15%) cases had BRCA1/2 gene mutations, of which BRCA1 mutations accounted for 13.48% (19/141), which was higher than BRCA2 (5.67% (8/141)) (Table 1). Here, BRCA2 is linked to ovarian cancer.